What You Should Know:
- U.S. hospitals and health systems continued to experience positive financial performance in April, with patient demand and revenues rising for the 12th consecutive month, according to new data from Strata Decision Technology.
- While hospitals and health systems experienced positive financial performance in April, rising expenses remain a concern. Continued monitoring of these trends will be crucial for understanding the overall health of the healthcare
Read More
J.D. Power Study Reveals Growing Gap in Commercial Health Plan Satisfaction
What You Should Know:
- The J.D. Power 2024 U.S. Commercial Member Health Plan Study, released, highlights a significant gap in customer satisfaction between different health insurance providers. While overall satisfaction has increased slightly, the difference between the top and bottom-ranked plans has widened significantly.
- The study, now in its 18th year, surveyed nearly 30,000 commercial health plan members across 22 regions. It measures satisfaction based on eight core
Read More
Weave Bio Launches for AI-Powered Drug Development, Secures $10M
What You Should Know:
- Weave Bio, an AI-native life sciences platform company, announced today the public release of its flagship offering, AutoIND, and $10 million in seed funding co-led by Innovation Endeavors and Magnetic Ventures.
- AutoIND marks a significant advancement in drug development by automating and accelerating the preparation, writing, and review process for Investigational New Drug (IND) applications.
Automating the IND Process: A Game-Changer for Drug
Read More
Virtual Therapeutics Acquires Akili: Stock to Go Private After Merger
What You Should Know:
- Virtual Therapeutics, a leader in using engaging games for mental health treatment, announced today it will acquire Akili, Inc. (Nasdaq: AKLI), a prominent digital therapeutics company. This merger creates a diversified powerhouse in the digital health industry.
- Once the acquisition is complete, Akili's common stock will be delisted from all public stock exchanges. The combined entity's focus on mental health and broader digital therapeutics solutions
Read More
Medable Partners with Masimo to Bring Wearable Devices to Clinical Research, Capturing Better Data
What You Should Know:
- Medable Inc., a leader in modern clinical trial technology, has announced a groundbreaking partnership with Masimo (NASDAQ: MASI) to integrate medical-grade wearable devices into clinical research. This collaboration aims to streamline patient participation and enhance data collection for clinical trials.
- By offering a patient-centric approach and fostering richer data collection, this collaboration holds promise for faster drug development, improved patient
Read More
New AI Test Aims to Improve Breast Cancer Recurrence Prediction: COTA, PreciseDx, and Baptist Health South Florida Collaborate
What You Should Know:
- A collaborative effort between COTA, PreciseDx, and Baptist Health South Florida seeks to revolutionize breast cancer recurrence risk assessment with the PreciseBreast™ (PDxBr) test. This AI-powered tool holds promise for faster, more accurate, and more affordable risk prediction compared to current methods.
- By utilizing AI technology, PreciseBreast™ has the potential to offer patients a faster, more accurate, and more affordable way to assess their risk of
Read More
HouseWorks Acquires AccordCare’s Connecticut Personal Care Division
What You Should Know:
- HouseWorks Holdings, LLC, a leading personal care services provider in the Northeast, today announced the acquisition of the Connecticut Personal Care Division of AccordCare.
- The acquisition marks HouseWorks' entry into the Connecticut market, significantly expanding their geographic reach and service offerings.
Expanding Services and Entering New Territory
The Connecticut Personal Care Division, encompassing Companions and Homemakers, LLC and
Read More
Veradigm Announces Leadership Changes Amidst Strategic Review
What You Should Know:
- Veradigm Inc. (OTCMKTS: MDRX), a leading healthcare data and technology company, announced today that it will be undergoing leadership changes as it explores strategic alternatives.
- Effective June 7th, 2024, Tom Langan, currently serving as Veradigm's President and Chief Commercial Officer (CCO), will assume the role of interim Chief Executive Officer (CEO). Mr. Langan is a seasoned leader with over 25 years of experience in life sciences, payer industries,
Read More
CVS + Echo Health Makes Strategic Investment in Thyme Care
What You Should Know:
- Thyme Care, a leader in value-based cancer care, has announced a strategic investment from Echo Health Ventures and CVS Health Ventures. Both partners have identified Thyme Care’s provider-centric approach as the only way to improve the patient experience and reduce costs across the care continuum. The investment was part of Thyme’s Series B fundraise.
- The strategic funding will fuel the national expansion of Thyme Care's innovative model, aiming to improve
Read More
Sheba Medical Center & Salignostics to Develop Saliva Test for Early Oral Cancer Detection
What You Should Know:
- Jerusalem-based Salignostics, a company specializing in rapid tests using saliva samples, has joined forces with ARC Innovation, the innovation arm of Sheba Medical Center, in a groundbreaking initiative.
- The strategic partnership is focused on developing a revolutionary test for early detection of oral cavity cancer through saliva analysis.
Early Detection: A Critical Need in Oral Cancer
Globally, over 400,000 individuals are diagnosed with
Read More
